Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Buy
64
PHR Quote, Financials, Valuation and Earnings
Last price:
$26.89
Seasonality move
:
-3.54%
Day range:
$26.49 - $27.14
52-week range:
$17.07 - $30.53
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.62x
P/B ratio:
5.70x
Volume:
297.3K
Avg. volume:
589K
1-year change:
11%
Market cap:
$1.6B
Revenue:
$419.8M
EPS (TTM):
-$0.74
Analysts' Opinion
-
Consensus RatingPhreesia has received a consensus rating of Buy. The company's average rating is a Buy based on 10 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $32.14, Phreesia has an estimated upside of 18.87% from its current price of $27.04.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $29.00 representing 100% downside risk from its current price of $27.04.
Fair Value
-
According to the consensus of 10 analysts, Phreesia has 18.87% upside to fair value with a price target of $32.14 per share.
PHR vs. S&P 500
-
Over the past 5 trading days, Phreesia has underperformed the S&P 500 by -6.69% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Phreesia does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Phreesia has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Phreesia reported revenues of $115.9M.
Earnings Growth
-
Phreesia has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Phreesia reported earnings per share of -$0.07.
Enterprise value:
1.5B
EV / Invested capital:
5.17x
Price / LTM sales:
3.62x
EV / EBIT:
--
EV / Revenue:
3.53x
PEG ratio (5yr expected):
--
EV / Free cash flow:
69.93x
Price / Operating cash flow:
71.74x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$295.6M
Return On Assets:
-11.25%
Net Income Margin (TTM):
-9.83%
Return On Equity:
-16.36%
Return On Invested Capital:
-16.16%
Operating Margin:
-2.84%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-04-30 | 2024-04-30 | 2025-04-30 | 2024-04-30 | 2025-04-30 | |
| Income Statement | ||||||
| Revenue | $301.4M | $373.7M | $434.5M | $101.2M | $115.9M | |
| Gross Profit | $187.7M | $246.6M | $295.6M | $67.2M | $77.9M | |
| Operating Income | -$163.9M | -$118M | -$42M | -$19.4M | -$3.3M | |
| EBITDA | -$134.2M | -$86M | -$9.5M | -$12M | $4.1M | |
| Diluted EPS | -$3.07 | -$2.17 | -$0.74 | -$0.35 | -$0.07 | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $507.2M | $349.2M | $240.1M | $190.9M | $215.4M | |
| Total Assets | $561.2M | $459.1M | $353.9M | $372.1M | $400.4M | |
| Current Liabilities | $50.7M | $70.8M | $83M | $108.3M | $110.7M | |
| Total Liabilities | $57.9M | $77.9M | $90.2M | $119.3M | $118.2M | |
| Total Equity | $503.3M | $381.2M | $263.6M | $252.7M | $282.2M | |
| Total Debt | $9.6M | $12.1M | -- | -- | $14.5M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-04-30 | 2024-04-30 | 2025-04-30 | 2024-04-30 | 2025-04-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$70.1M | -$19.4M | $48M | -$721K | $14.9M | |
| Cash From Investing | -$25.3M | -$39M | -$26M | -$5.4M | -$7.4M | |
| Cash From Financing | -$24M | -$11.8M | -$10.5M | -$1.8M | -$838K | |
| Free Cash Flow | -$95.4M | -$43.9M | $21.9M | -$6.2M | $7.5M | |
PHR
Sector
Market Cap
$1.6B
$34.4M
Price % of 52-Week High
88.57%
48.88%
Dividend Yield
0%
0%
Shareholder Yield
-0.02%
-1.01%
1-Year Price Total Return
11%
-37.36%
Beta (5-Year)
0.719
0.614
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$27.82
200-day SMA
Buy
Level
$24.74
Bollinger Bands (100)
Buy
Level
24.35 - 27.63
Chaikin Money Flow
Sell
Level
-618.3K
20-day SMA
Sell
Level
$27.69
Relative Strength Index (RSI14)
Sell
Level
48.02
ADX Line
Sell
Level
31.11
Williams %R
Buy
Level
-80.2139
50-day SMA
Buy
Level
$26.40
MACD (12, 26)
Buy
Level
7.46
25-day Aroon Oscillator
Buy
Level
44
On Balance Volume
Neutral
Level
496K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (6.1266)
Buy
CA Score
(Annual)
Level (0.1626)
Buy
Beneish M-Score
(Annual)
Level (-3.4199)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (1.1425)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys.
Stock Forecast FAQ
In the current month, PHR has received 10 Buy ratings 0 Hold ratings, and 0 Sell ratings. The PHR average analyst price target in the past 3 months is $32.14.
-
Where Will Phreesia Stock Be In 1 Year?
According to analysts, the consensus estimate is that Phreesia share price will rise to $32.14 per share over the next 12 months.
-
What Do Analysts Say About Phreesia?
Analysts are divided on their view about Phreesia share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Phreesia is a Sell and believe this share price will drop from its current level to $29.00.
-
What Is Phreesia's Price Target?
The price target for Phreesia over the next 1-year time period is forecast to be $32.14 according to 10 Wall Street analysts, 10 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is PHR A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Phreesia is a Buy. 10 of 10 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of PHR?
You can purchase shares of Phreesia via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Phreesia shares.
-
What Is The Phreesia Share Price Today?
Phreesia was last trading at $26.89 per share. This represents the most recent stock quote for Phreesia. Yesterday, Phreesia closed at $27.04 per share.
-
How To Buy Phreesia Stock Online?
In order to purchase Phreesia stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
How High Can SharkNinja Stock Go?
If you know popular consumer appliance brands Shark and Ninja,…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 3.08% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 1.75% over the past day.
Sell
42
VLCN alert for Jul 17
Volcon [VLCN] is up 256.56% over the past day.
